The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...

The FDA has introduced ELSA, a groundbreaking AI tool designed to expedite the review process for drugs and medical devices.

FDA announced the launch of Elsa, a generative AI tool designed to “help employees—from scientific reviewers to ...

Modern drug development approaches that integrate functional plans with larger business goals are needed for success in early ...

The FDA will now work with the companies to make ... The new strategy would continue the current vaccine approval process for people ages 65 and older and younger people with health problems ...

"The claim that the FDA is suspending routine food safety inspections is false. FDA is actively working to ensure continuity of operations during the reorganization period and remains committed to ...

Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy from the FDA. If drugmakers want healthier people to have access to the ...

The FDA will make it more costly to seek approval of Covid-19 vaccines, but investors of vaccine drugmakers like Moderna find it's not as bad as many investors had feared. 2025 Best Places to Work ...

The U.S. Food and Drug Administration (FDA) is moving to restrict COVID vaccination ... On one hand, he views it as encouraging that the process for evaluating and approving new versions of ...

The Food and Drug Administration is shifting its annual COVID-19 vaccine approval policies to focus ... vaccines for low-risk individuals. "The FDA will approve vaccines for high-risk persons ...

Previously, the FDA typically approved updated Covid shots for all Americans each year based on simple tests that show they trigger a strong enough antibody response. "The truth is that for most ...